Related Experiment Video
Updated: Aug 8, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
MUC-FIRE: Study protocol for a randomized multicenter open-label controlled trial to show that MUCous FIstula
Anika Großhennig1, Sören Wiesner1, Juliane Hellfritsch2
1Institute of Biostatistics, Hannover Medical School, Germany.
Insights
Mucous fistula refeeding (MFR) in infants significantly reduces the time to full enteral feeds after ostomy closure. This approach also shortens hospital stays and minimizes parenteral nutrition complications.
Area of Science:
- Pediatric Surgery
- Neonatal Nutrition
- Gastroenterology
Background:
- Enterostomy in infants excludes the distal bowel, leading to growth issues and reliance on parenteral nutrition.
- Mucous fistula refeeding (MFR) has shown promise in improving infant weight gain.
- Significant diameter discrepancies between proximal and distal bowel necessitate prolonged nutritional support post-enterostomy reversal.
Purpose of the Study:
- To evaluate if perioperative mucous fistula refeeding (MFR) reduces time to full enteral feeds post-enterostomy closure in infants.
- To assess MFR's impact on hospital stay duration and adverse effects of parenteral nutrition.
- To establish evidence-based guidelines for MFR in pediatric surgical care.
Main Methods:
- A randomized multicenter open-label controlled trial (MUC-FIRE) involving 120 infants.
- Infants randomized to either perioperative MFR (intervention group) or standard care (control group) after enterostomy creation.
- Primary endpoint: time to full enteral feeds; secondary endpoints: postoperative outcomes and adverse events.
Main Results:
- The MUC-FIRE trial aims to demonstrate MFR's efficacy in accelerating enteral feeding post-enterostomy closure.
- Expected results will quantify reductions in hospital stay and parenteral nutrition-related complications.
- Analysis of adverse events will provide a comprehensive safety profile of MFR.
Conclusions:
- MFR is a promising intervention for infants with enterostomy, potentially improving nutritional outcomes.
- The MUC-FIRE trial will provide crucial evidence to guide clinical practice in neonatal surgery.
- Findings are expected to influence worldwide pediatric surgical guidelines regarding MFR.
Background:
After enterostomy creation, the distal bowel to the ostomy is excluded from the physiologic passage of stool, nutrient uptake, and growth of this intestinal section. Those infants frequently require long-term parenteral nutrition, continued after enterostomy reversal due to the notable diameter discrepancy of the proximal and distal bowel. Previous studies have shown that mucous fistula refeeding (MFR) results in faster weight gain in infants. The aim of the randomized multicenter open-label controlled MUCous FIstula REfeeding ("MUC-FIRE") trial is to demonstrate that MFR between enterostomy creation and reversal reduces the time to full enteral feeds after enterostomy closure compared to controls, resulting in shorter hospital stay and less adverse effects of parenteral nutrition. A total of 120 infants will be included in the MUC-FIRE trial. Following enterostomy creation, infants will be randomized to either an intervention or a non-intervention group.In the intervention group, perioperative MFR between enterostomy creation and reversal will be performed. The control group receives standard care without MFR.The primary efficacy endpoint of the study is the time to full enteral feeds. Secondary endpoints include first postoperative bowel movement after stoma reversal, postoperative weight gain, and days of postoperative parenteral nutrition. In addition adverse events will be analyzed.
Discussion:
The MUC-FIRE trial will be the first prospective randomized trial to investigate the benefits and disadvantages of MFR in infants. The results of the trial are expected to provide an evidence-based foundation for guidelines in pediatric surgical centers worldwide.
Trial Registration:
The trial has been registered at clinicaltrials.gov (number: NCT03469609, date of registration: March 19, 2018; last update: January 20, 2023, https://clinicaltrials.gov/ct2/show/NCT03469609?term=NCT03469609&draw=2&rank=1).
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

